ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
value factor · long-only model fund

Foundry OCFP Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FOCRHYPOTHETICAL MODEL
Since ’99
+57%
Expense Ratio
0.35%
placeholder
Holdings
296
cap-weighted
Inception
Mar 2019
placeholder
Full Sharpe
0.18
Ann. Return (LS)
2.9%
Ann. Volatility
15.8%
Max Drawdown
-52.1%
Test Sharpe ’19–26
0.20
Test FF5 α (ann.)
6.0%
vs Fama-French 5
Test FF5 α t-stat
1.08
not significant
Monthly turnover
30%
of the long leg, per rebalance
Cumulative return (LS)
57%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.59
what this fund holds
Long leg ann. return
9.7%
buyable, long-only
Long-short Sharpe
0.18
requires shorting
Bottom bucket ann. return
6.8%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1LLY
ELI LILLY & COHealthcare$1.11T
14.49%
2JNJ
JOHNSON & JOHNSONHealthcare$609.12B
7.95%
3ABBV
ABBVIE INCHealthcare$449.63B
5.87%
4KO
COCA COLA COConsumer Defensive$350.91B
4.58%
5MRK
MERCK & CO INCHealthcare$314.90B
4.11%
6PM
PHILIP MORRIS INTERNATIONAL INCConsumer Defensive$300.77B
3.92%
7NFLX
NETFLIX INCCommunication Services$290.47B
3.79%
8AMGN
AMGEN INCHealthcare$197.69B
2.58%
9PEP
PEPSICO INCConsumer Defensive$187.15B
2.44%
10ABT
ABBOTT LABORATORIESHealthcare$175.37B
2.29%
11DIS
WALT DISNEY COCommunication Services$169.61B
2.21%
12GILD
GILEAD SCIENCES INCHealthcare$166.72B
2.18%
13PFE
PFIZER INCHealthcare$142.77B
1.86%
14BMY
BRISTOL MYERS SQUIBB COHealthcare$124.04B
1.62%
15MO
ALTRIA GROUP INCConsumer Defensive$123.92B
1.62%
16VRTX
VERTEX PHARMACEUTICALS INCHealthcare$123.26B
1.61%
17SYK
STRYKER CORPHealthcare$122.63B
1.60%
18ISRG
INTUITIVE SURGICAL INCHealthcare$122.33B
1.60%
19MDT
MEDTRONIC PLCHealthcare$106.50B
1.39%
20MCK
MCKESSON CORPHealthcare$101.14B
1.32%
21WM
WASTE MANAGEMENT INCIndustrials$96.10B
1.25%
22MMM
3M COIndustrials$83.37B
1.09%
23REGN
REGENERON PHARMACEUTICALS INCHealthcare$70.94B
0.93%
24RSG
REPUBLIC SERVICES INCIndustrials$68.40B
0.89%
25GWW
WW GRAINGER INCIndustrials$65.86B
0.86%
26BSX
BOSTON SCIENTIFIC CORPHealthcare$65.44B
0.85%
27HPE
HEWLETT PACKARD ENTERPRISE COTechnology$60.67B
0.79%
28COR
CENCORA INCHealthcare$59.91B
0.78%
29TEL
TE CONNECTIVITY PLCTechnology$59.35B
0.77%
30CTVA
CORTEVA INCBasic Materials$58.39B
0.76%
31CAH
CARDINAL HEALTH INCHealthcare$53.52B
0.70%
32EW
EDWARDS LIFESCIENCES CORPHealthcare$49.36B
0.64%
33IDXX
IDEXX LABORATORIES INCHealthcare$44.76B
0.58%
34WCN
WASTE CONNECTIONS INCIndustrials$43.68B
0.57%
35BDX
BECTON DICKINSON & COHealthcare$43.58B
0.57%
36LYV
LIVE NATION ENTERTAINMENT INCCommunication Services$42.45B
0.55%
37KDP
KEURIG DR PEPPER INCConsumer Defensive$42.05B
0.55%
38SYY
SYSCO CORPConsumer Defensive$39.06B
0.51%
39TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTDHealthcare$37.30B
0.49%
40ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
0.47%
41TKO
TKO GROUP HOLDINGS INCCommunication Services$35.38B
0.46%
42ONC
BEONE MEDICINES LTDHealthcare$34.68B
0.45%
43RPRX
ROYALTY PHARMA PLCHealthcare$33.50B
0.44%
44ZTS
ZOETIS INCHealthcare$32.10B
0.42%
45BIIB
BIOGEN INCHealthcare$30.41B
0.40%
46DXCM
DEXCOM INCHealthcare$29.58B
0.39%
47RMD
RESMED INCHealthcare$28.86B
0.38%
48GEHC
GE HEALTHCARE TECHNOLOGIES INCHealthcare$28.69B
0.37%
49UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.30%
50STZ
CONSTELLATION BRANDS INCConsumer Defensive$22.69B
0.30%
51USFD
US FOODS HOLDING CORPConsumer Defensive$21.42B
0.28%
52STE
STERIS PLCHealthcare$21.26B
0.28%
53RS
RELIANCE INCBasic Materials$20.21B
0.26%
54VTRS
VIATRIS INCHealthcare$20.14B
0.26%
55SNX
TD SYNNEX CORPTechnology$19.40B
0.25%
56ZBH
ZIMMER BIOMET HOLDINGS INCHealthcare$17.63B
0.23%
57PFGC
PERFORMANCE FOOD GROUP COConsumer Defensive$17.56B
0.23%
58NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.22%
59GPC
GENUINE PARTS COConsumer Cyclical$17.18B
0.22%
60CLH
CLEAN HARBORS INCIndustrials$16.41B
0.21%
61CHTR
CHARTER COMMUNICATIONS INCCommunication Services$16.16B
0.21%
62WCC
WESCO INTERNATIONAL INCIndustrials$15.97B
0.21%
63JAZZ
JAZZ PHARMACEUTICALS PLCHealthcare$15.53B
0.20%
64WSO
WATSCO INCIndustrials$15.12B
0.20%
65WMG
WARNER MUSIC GROUP CORPCommunication Services$14.78B
0.19%
66SOLV
SOLVENTUM CORPHealthcare$14.08B
0.18%
67COO
COOPER COMPANIES INCHealthcare$13.99B
0.18%
68ELAN
ELANCO ANIMAL HEALTH INCHealthcare$12.90B
0.17%
69ALGN
ALIGN TECHNOLOGY INCHealthcare$12.66B
0.17%
70PEN
PENUMBRA INCHealthcare$12.52B
0.16%
71AIT
APPLIED INDUSTRIAL TECHNOLOGIES INCIndustrials$12.43B
0.16%
72DKNG
DRAFTKINGS INCConsumer Cyclical$12.37B
0.16%
73BF.B
BROWN FORMAN CORPConsumer Defensive$11.74B
0.15%
74BAX
BAXTER INTERNATIONAL INCHealthcare$11.68B
0.15%
75BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.15%
76PODD
INSULET CORPHealthcare$11.36B
0.15%
77TECH
BIO-TECHNE CORPHealthcare$11.29B
0.15%
78DPZ
DOMINOS PIZZA INCConsumer Cyclical$10.72B
0.14%
79ARW
ARROW ELECTRONICS INCTechnology$10.56B
0.14%
80AES
AES CORPUtilities$10.53B
0.14%
81KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.14%
82GMED
GLOBUS MEDICAL INCHealthcare$10.45B
0.14%
83HSIC
HENRY SCHEIN INCHealthcare$10.00B
0.13%
84AAL
AMERICAN AIRLINES GROUP INCIndustrials$9.91B
0.13%
85MSGS
MADISON SQUARE GARDEN SPORTS CORPCommunication Services$9.56B
0.12%
86LTH
LIFE TIME GROUP HOLDINGS INCConsumer Cyclical$9.38B
0.12%
87HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.12%
88GKOS
GLAUKOS CORPHealthcare$9.21B
0.12%
89ALKS
ALKERMES PLCHealthcare$8.79B
0.11%
90CNM
CORE & MAIN INCIndustrials$8.75B
0.11%
91RGEN
REPLIGEN CORPHealthcare$8.31B
0.11%
92RSI
RUSH STREET INTERACTIVE INCConsumer Cyclical$7.56B
0.10%
93POOL
POOL CORPIndustrials$7.33B
0.10%
94TAP
MOLSON COORS BEVERAGE COConsumer Defensive$7.28B
0.09%
95ENS
ENERSYSIndustrials$7.18B
0.09%
96LQDA
LIQUIDIA CORPHealthcare$7.11B
0.09%
97AVT
AVNET INCTechnology$7.03B
0.09%
98LNTH
LANTHEUS HOLDINGS INCHealthcare$7.00B
0.09%
99MSM
MSC INDUSTRIAL DIRECT CO INCIndustrials$6.97B
0.09%
100INGM
INGRAM MICRO HOLDING CORPTechnology$6.78B
0.09%
101MSA
MSA SAFETY INCIndustrials$6.60B
0.09%
102LKQ
LKQ CORPConsumer Cyclical$6.47B
0.08%
103CWST
CASELLA WASTE SYSTEMS INCIndustrials$6.09B
0.08%
104LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.08%
105TFX
TELEFLEX INCHealthcare$5.96B
0.08%
106CHDN
CHURCHILL DOWNS INCConsumer Cyclical$5.85B
0.08%
107BLCO
BAUSCH & LOMB CORPHealthcare$5.80B
0.08%
108AMRX
AMNEAL PHARMACEUTICALS INCHealthcare$5.69B
0.07%
109CAR
AVIS BUDGET GROUP INCIndustrials$5.67B
0.07%
110REZI
RESIDEO TECHNOLOGIES INCIndustrials$5.43B
0.07%
111MTN
VAIL RESORTS INCConsumer Cyclical$5.27B
0.07%
112SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.07%
113PAGP
PLAINS GP HOLDINGS LPEnergy$5.07B
0.07%
114KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.06%
115MRP
MILLROSE PROPERTIES INCReal Estate$4.89B
0.06%
116MMED
MINIMED GROUP INCHealthcare$4.75B
0.06%
117SITE
SITEONE LANDSCAPE SUPPLY INCIndustrials$4.60B
0.06%
118LIVN
LIVANOVA PLCHealthcare$4.43B
0.06%
119MMSI
MERIT MEDICAL SYSTEMS INCHealthcare$4.41B
0.06%
120ACAD
ACADIA PHARMACEUTICALS INCHealthcare$4.38B
0.06%
121NVST
ENVISTA HOLDINGS CORPHealthcare$4.35B
0.06%
122FG
F&G ANNUITIES & LIFE INCFinancial Services$4.25B
0.06%
123CALM
CAL-MAINE FOODS INCConsumer Defensive$4.20B
0.05%
124COCO
VITA COCO COMPANY INCConsumer Defensive$4.18B
0.05%
125PLNT
PLANET FITNESS INCConsumer Cyclical$4.16B
0.05%
126LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.05%
127BFH
BREAD FINANCIAL HOLDINGS INCFinancial Services$4.01B
0.05%
128CHEF
CHEFS' WAREHOUSE INCConsumer Defensive$3.96B
0.05%
129ICUI
ICU MEDICAL INCHealthcare$3.94B
0.05%
130CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.05%
131IRTC
IRHYTHM HOLDINGS INCHealthcare$3.64B
0.05%
132BATRA
ATLANTA BRAVES HOLDINGS INCCommunication Services$3.63B
0.05%
133MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.05%
134CNK
CINEMARK HOLDINGS INCCommunication Services$3.55B
0.05%
135OGN
ORGANON & COHealthcare$3.55B
0.05%
136HAE
HAEMONETICS CORPHealthcare$3.54B
0.05%
137WRBY
WARBY PARKER INCHealthcare$3.24B
0.04%
138ASH
ASHLAND INCBasic Materials$3.14B
0.04%
139HWKN
HAWKINS INCBasic Materials$3.01B
0.04%
140UNFI
UNITED NATURAL FOODS INCConsumer Defensive$2.97B
0.04%
141XRAY
DENTSPLY SIRONA INCHealthcare$2.81B
0.04%
142SUPN
SUPERNUS PHARMACEUTICALS INCHealthcare$2.79B
0.04%
143CENT
CENTRAL GARDEN & PET COConsumer Defensive$2.73B
0.04%
144ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.04%
145BCC
BOISE CASCADE COBasic Materials$2.72B
0.04%
146ANDE
ANDERSONS INCConsumer Defensive$2.70B
0.04%
147OSW
ONESPAWORLD HOLDINGS LTDConsumer Cyclical$2.68B
0.03%
148DXPE
DXP ENTERPRISES INCIndustrials$2.60B
0.03%
149TMDX
TRANSMEDICS GROUP INCHealthcare$2.56B
0.03%
150VCEL
VERICEL CORPHealthcare$2.38B
0.03%
151PBH
PRESTIGE CONSUMER HEALTHCARE INCHealthcare$2.36B
0.03%
152BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.03%
153PLUS
EPLUS INCTechnology$2.33B
0.03%
154LMAT
LEMAITRE VASCULAR INCHealthcare$2.32B
0.03%
155NEOG
NEOGEN CORPHealthcare$2.24B
0.03%
156VSTS
VESTIS CORPIndustrials$2.18B
0.03%
157HTFL
HEARTFLOW INCHealthcare$2.15B
0.03%
158PRKS
UNITED PARKS & RESORTS INCConsumer Cyclical$2.13B
0.03%
159AXGN
AXOGEN INCHealthcare$2.12B
0.03%
160AUPH
AURINIA PHARMACEUTICALS INCHealthcare$2.05B
0.03%
161ADMA
ADMA BIOLOGICS INCHealthcare$2.02B
0.03%
162PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.03%
163HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.03%
164WKC
WORLD KINECT CORPEnergy$1.87B
0.02%
165UFPT
UFP TECHNOLOGIES INCHealthcare$1.87B
0.02%
166SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.02%
167NVCR
NOVOCURE LTDHealthcare$1.84B
0.02%
168SRPT
SAREPTA THERAPEUTICS INCHealthcare$1.82B
0.02%
169ANIP
ANI PHARMACEUTICALS INCHealthcare$1.80B
0.02%
170GEL
GENESIS ENERGY LPEnergy$1.79B
0.02%
171FUN
SIX FLAGS ENTERTAINMENT CORPORATIONConsumer Cyclical$1.79B
0.02%
172ATRC
ATRICURE INCHealthcare$1.77B
0.02%
173BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.02%
174EYE
NATIONAL VISION HOLDINGS INCConsumer Cyclical$1.66B
0.02%
175GLP
GLOBAL PARTNERS LPEnergy$1.63B
0.02%
176TPB
TURNING POINT BRANDS INCConsumer Defensive$1.60B
0.02%
177INVA
INNOVIVA INCHealthcare$1.60B
0.02%
178DSGR
DISTRIBUTION SOLUTIONS GROUP INCIndustrials$1.59B
0.02%
179DXC
DXC TECHNOLOGY COTechnology$1.55B
0.02%
180RYZ
RYERSON HOLDING CORPIndustrials$1.54B
0.02%
181XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.02%
182SEPN
SEPTERNA INCHealthcare$1.51B
0.02%
183IART
INTEGRA LIFESCIENCES HOLDINGS CORPHealthcare$1.50B
0.02%
184PRGO
PERRIGO CO PLCHealthcare$1.48B
0.02%
185INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.02%
186KMTS
KESTRA MEDICAL TECHNOLOGIES LTDHealthcare$1.43B
0.02%
187BLFS
BIOLIFE SOLUTIONS INCHealthcare$1.42B
0.02%
188DMC
DEL MONTE CORPConsumer Defensive$1.40B
0.02%
189AMN
AMN HEALTHCARE SERVICES INCHealthcare$1.36B
0.02%
190BV
BRIGHTVIEW HOLDINGS INCIndustrials$1.35B
0.02%
191PAHC
PHIBRO ANIMAL HEALTH CORPHealthcare$1.35B
0.02%
192WLFC
WILLIS LEASE FINANCE CORPIndustrials$1.35B
0.02%
193FBYD
FALCON'S BEYOND GLOBAL INCIndustrials$1.35B
0.02%
194UVV
UNIVERSAL CORPConsumer Defensive$1.32B
0.02%
195GIC
GLOBAL INDUSTRIAL COIndustrials$1.32B
0.02%
196STAA
STAAR SURGICAL COHealthcare$1.32B
0.02%
197ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.02%
198CNMD
CONMED CORPHealthcare$1.30B
0.02%
199CDRE
CADRE HOLDINGS INCIndustrials$1.24B
0.02%
200HLF
HERBALIFE LTDConsumer Defensive$1.24B
0.02%
201IRMD
IRADIMED CORPHealthcare$1.24B
0.02%
202AORT
ARTIVION INCHealthcare$1.22B
0.02%
203AVO
MISSION PRODUCE INCConsumer Defensive$1.20B
0.02%
204DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.02%
205TNDM
TANDEM DIABETES CARE INCHealthcare$1.17B
0.02%
206COLL
COLLEGIUM PHARMACEUTICAL INCHealthcare$1.17B
0.02%
207AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.02%
208SCSC
SCANSOURCE INCTechnology$1.11B
0.01%
209PRCT
PROCEPT BIOROBOTICS CORPHealthcare$1.09B
0.01%
210GOLD
GOLDCOM INCFinancial Services$1.09B
0.01%
211FUBO
FUBOTV INCCommunication Services$1.05B
0.01%
212LUCK
LUCKY STRIKE ENTERTAINMENT CORPConsumer Cyclical$1.01B
0.01%
213PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.01%
214BVS
BIOVENTUS INCHealthcare$1.01B
0.01%
215ACEL
ACCEL ENTERTAINMENT INCConsumer Cyclical$989M
0.01%
216TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.01%
217AMPH
AMPHASTAR PHARMACEUTICALS INCHealthcare$871M
0.01%
218CAPL
CROSSAMERICA PARTNERS LPEnergy$856M
0.01%
219AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.01%
220RJET
REPUBLIC AIRWAYS HOLDINGS INCIndustrials$806M
0.01%
221SIBN
SI-BONE INCHealthcare$771M
0.01%
222BBNX
BETA BIONICS INCHealthcare$771M
0.01%
223ZVRA
ZEVRA THERAPEUTICS INCHealthcare$755M
0.01%
224RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.01%
225WEST
WESTROCK COFFEE COConsumer Defensive$749M
0.01%
226KODK
EASTMAN KODAK COIndustrials$748M
0.01%
227CBLL
CERIBELL INCHealthcare$710M
0.01%
228MCS
MARCUS CORPCommunication Services$708M
0.01%
229RSVR
RESERVOIR MEDIA INCCommunication Services$671M
0.01%
230CRMD
CORMEDIX INCHealthcare$661M
0.01%
231TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.01%
232AENT
ALLIANCE ENTERTAINMENT HOLDING CORPCommunication Services$641M
0.01%
233ALIT
ALIGHT INCTechnology$584M
0.01%
234ANGO
ANGIODYNAMICS INCHealthcare$558M
0.01%
235NPCE
NEUROPACE INCHealthcare$548M
0.01%
236KIDS
ORTHOPEDIATRICS CORPHealthcare$494M
0.01%
237CLMB
CLIMB GLOBAL SOLUTIONS INCTechnology$482M
0.01%
238BXC
BLUELINX HOLDINGS INCIndustrials$471M
0.01%
239OFIX
ORTHOFIX MEDICAL INCHealthcare$468M
0.01%
240CLPT
CLEARPOINT NEURO INCHealthcare$454M
0.01%
241STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.01%
242SI
SHOULDER INNOVATIONS INCHealthcare$448M
0.01%
243DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.01%
244FSTR
FOSTER L B COIndustrials$439M
0.01%
245PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.01%
246ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.01%
247USNA
USANA HEALTH SCIENCES INCConsumer Defensive$403M
0.01%
248EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.01%
249RM
REGIONAL MANAGEMENT CORPFinancial Services$384M
0.01%
250MGPI
MGP INGREDIENTS INCConsumer Defensive$382M
0.00%
251WEYS
WEYCO GROUP INCConsumer Cyclical$374M
0.00%
252NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
253PLAY
DAVE & BUSTER'S ENTERTAINMENT INCCommunication Services$355M
0.00%
254ELMD
ELECTROMED INCHealthcare$349M
0.00%
255CV
CAPSOVISION INCHealthcare$335M
0.00%
256SEG
SEAPORT ENTERTAINMENT GROUP INCReal Estate$332M
0.00%
257XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.00%
258PESI
PERMA FIX ENVIRONMENTAL SERVICES INCIndustrials$324M
0.00%
259CARL
CARLSMED INCHealthcare$317M
0.00%
260ALCO
ALICO INCConsumer Defensive$304M
0.00%
261ASLE
AERSALE CORPIndustrials$286M
0.00%
262OPRT
OPORTUN FINANCIAL CORPFinancial Services$274M
0.00%
263SGHT
SIGHT SCIENCES INCHealthcare$274M
0.00%
264SSTK
SHUTTERSTOCK INCCommunication Services$272M
0.00%
265HDSN
HUDSON TECHNOLOGIES INCBasic Materials$260M
0.00%
266NUS
NU SKIN ENTERPRISES INCConsumer Defensive$254M
0.00%
267RELL
RICHARDSON ELECTRONICS LTDTechnology$250M
0.00%
268LMNR
LIMONEIRA COConsumer Defensive$245M
0.00%
269GTE
GRAN TIERRA ENERGY INCEnergy$233M
0.00%
270RXST
RXSIGHT INCHealthcare$230M
0.00%
271SMTI
SANARA MEDTECH INCHealthcare$229M
0.00%
272CABO
CABLE ONE INCCommunication Services$223M
0.00%
273UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.00%
274ALTG
ALTA EQUIPMENT GROUP INCIndustrials$208M
0.00%
275FOCL
FOCAL INCHealthcare$204M
0.00%
276ANIK
ANIKA THERAPEUTICS INCHealthcare$203M
0.00%
277CPSS
CONSUMER PORTFOLIO SERVICES INCFinancial Services$197M
0.00%
278PDEX
PRO DEX INCHealthcare$183M
0.00%
279INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
280INGN
INOGEN INCHealthcare$178M
0.00%
281RCEL
AVITA MEDICAL INCHealthcare$157M
0.00%
282VATE
INNOVATE CORPIndustrials$123M
0.00%
283LAKE
LAKELAND INDUSTRIES INCConsumer Cyclical$113M
0.00%
284FTLF
FITLIFE BRANDS INCConsumer Defensive$104M
0.00%
285ICCC
IMMUCELL CORPHealthcare$101M
0.00%
286CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
287NRXS
NEURAXIS INCHealthcare$84M
0.00%
288CPHC
CANTERBURY PARK HOLDING CORPConsumer Cyclical$82M
0.00%
289LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
290SEAT
VIVID SEATS INCCommunication Services$78M
0.00%
291ROLR
HIGH ROLLER TECHNOLOGIES INCConsumer Cyclical$76M
0.00%
292AGPU
AXE COMPUTE INCHealthcare$72M
0.00%
293LNSR
LENSAR INCHealthcare$70M
0.00%
294DIT
AMCON DISTRIBUTING COConsumer Defensive$66M
0.00%
295SNWV
SANUWAVE HEALTH INCHealthcare$55M
0.00%
296APT
ALPHA PRO TECH LTDBasic Materials$53M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $7.66T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

11 sectors
Healthcare
65.4%
Consumer Defensive
15.1%
Communication Services
7.8%
Industrials
6.6%
Technology
2.2%
Consumer Cyclical
1.2%
Basic Materials
1.2%
Energy
0.1%
Utilities
0.1%
Financial Services
0.1%
Real Estate
0.1%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
7%10
41%41
47%51
1%23
1%31
1%42
<1%27
<1%27
<1%10

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 71% toward Growth. +1% unclassified (34 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt98% → Large
SmallLarge
Value ↔ growth tilt71% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    51.6%
    Margin
    -26.6%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.0 (95% CI 0.8-1.2)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
10.1%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.05x
within
parametric
1.03x
within
cornish fisher
1.18x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2004
Before publication (pre-2004)
-0.31
Sharpe · -6.2% p.a.
January 1999December 2004 · 72 mo
Since publication
0.38
Sharpe · 5.5% p.a.
January 2005July 2026 · 259 mo
Change in Sharpe+0.69the return flipped from negative to positive since publication

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
62%
16 of 26 3-year windows made money
Worst window
-0.82
Sharpe, January 2004 – December 2006
January 1999July 2026
Median Sharpe
0.22
Dispersion
0.68
Best window
1.37

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.18.3%-3.4%
3 yearsp.a.9.8%-10.0%
5 yearsp.a.8.0%-2.0%
10 yearsp.a.13.7%3.2%
Since inceptionp.a.8.6%1.7%
Calendar years
YearLong legLong-short
20267 mo3.1%-10.5%
202518.0%0.1%
20248.5%-10.9%
20230.3%-14.9%
20223.1%25.2%
202128.3%1.0%
202033.1%39.4%
201920.0%-2.1%
20184.2%25.1%
201725.9%14.3%
2016-0.3%-25.5%
20154.3%11.1%
201418.3%27.4%
201333.2%4.8%
201223.1%0.6%
2011-0.3%3.1%
201026.0%16.3%
200946.9%28.2%
2008-46.8%-8.4%
2007-8.3%8.6%
200613.5%-6.1%
20053.6%-3.3%
20049.6%-6.9%
200328.8%-7.0%
2002-26.1%-8.8%
2001-12.1%-2.0%
200026.1%23.1%
19998.8%-36.1%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FOCR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2019-03-11 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$7.66T

Methodology

The Foundry OCFP Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a OCFP signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.